pSivida Corp.
(NASDAQ : PSDV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Loading PSDV News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-3.48%80.471.8%$677.67m
BIIBBiogen Inc.
-4.02%229.021.0%$525.14m
CELGCelgene Corporation
-4.34%96.291.2%$438.11m
AMGNAmgen Inc.
-3.82%146.451.0%$388.51m
ANACAnacor Pharmaceuticals, Inc.
-0.14%99.0615.2%$320.35m
REGNRegeneron Pharmaceuticals, Inc.
-4.95%339.483.1%$301.85m
ALXNAlexion Pharmaceuticals, Inc.
-8.56%112.992.5%$274.13m
ILMNIllumina, Inc.
-5.24%138.914.9%$155.27m
VRTXVertex Pharmaceuticals Incorporated
-7.14%81.902.6%$124.14m
MDVNMedivation, Inc.
-3.90%56.952.8%$120.74m
BMRNBioMarin Pharmaceutical Inc.
-7.94%77.014.0%$117.35m
SRPTSarepta Therapeutics, Inc.
3.58%18.5249.4%$116.18m
CPXXCelator Pharmaceuticals, Inc.
0.13%30.198.5%$107.30m
AAgilent Technologies, Inc.
-5.48%44.121.0%$94.74m
IONSIonis Pharmaceuticals, Inc.
-6.91%21.978.6%$94.46m

Company Profile

pSivida Corp. develops tiny, sustained-release products, which are designed to deliver drugs and biologics at a controlled and steady rate for weeks, months or years. The company through its technology platforms Duraser and BioSilico is focused on treatment of chronic diseases of the back of the eye and are also exploring applications outside ophthalmology. It is also developing a bioerodible, injectable micro-insert delivering latanoprost to treat glaucoma and ocular hypertension. pSivida was founded by Roger Aston in March 2008 and is headquartered in Waterson, MA.